Exact Sciences

News

NICE backs wider tumour profiling use in early breast cancer

Three tests that can be used to profile tumours in people with breast cancer and predict whether they will respond to chemotherapy have been cleared for wider use by the N

Oncology

Redefining the approach to cancer care – a mission to improv...

Each year across Europe, 3.7 million people are diagnosed with a form of cancer, resulting in 1.9 million deaths, making cancer the

News

DNA strand and Cancer Cell Oncology Research Concept 3D rendering

Exact Sciences buys cancer detection company Thrive for $2.1...

Stocks for Exact Sciences leaped 33% after it announced the acquisition of liquid biopsy rival Thrive and UK start-up Base Genomics.

NICE backs wider tumour profiling use in early breast cancer

Redefining the approach to cancer care – a mission to improv...

Exact Sciences buys cancer detection company Thrive for $2.1...

NHS "isn't delivering equitable care for rare diseases"

Using AI-driven synthetic personas to take your insights fur...

Editor's Picks